CIP
Champlain Investment Partners’s Integra LifeSciences IART Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,687,972
| Closed | -$95.3M | – | 125 |
|
|
2024
Q1 | $95.3M | Buy |
2,687,972
+252,015
| +10% | +$8.93M | 0.55% | 74 |
|
|
2023
Q4 | $106M | Sell |
2,435,957
-2,872
| -0.1% | -$125K | 0.63% | 66 |
|
|
2023
Q3 | $93.1M | Sell |
2,438,829
-1,462,894
| -37% | -$55.9M | 0.6% | 68 |
|
|
2023
Q2 | $160M | Sell |
3,901,723
-1,269,936
| -25% | -$52.2M | 0.99% | 36 |
|
|
2023
Q1 | $297M | Sell |
5,171,659
-87,865
| -2% | -$5.04M | 1.87% | 7 |
|
|
2022
Q4 | $295M | Sell |
5,259,524
-100,031
| -2% | -$5.61M | 1.89% | 5 |
|
|
2022
Q3 | $227M | Sell |
5,359,555
-93,260
| -2% | -$3.95M | 1.55% | 10 |
|
|
2022
Q2 | $295M | Sell |
5,452,815
-132,915
| -2% | -$7.18M | 1.9% | 6 |
|
|
2022
Q1 | $359M | Sell |
5,585,730
-109,107
| -2% | -$7.01M | 1.86% | 5 |
|
|
2021
Q4 | $381M | Sell |
5,694,837
-32,400
| -0.6% | -$2.17M | 1.73% | 6 |
|
|
2021
Q3 | $392M | Sell |
5,727,237
-782,793
| -12% | -$53.6M | 1.88% | 3 |
|
|
2021
Q2 | $444M | Sell |
6,510,030
-19,145
| -0.3% | -$1.31M | 2.11% | 2 |
|
|
2021
Q1 | $451M | Buy |
6,529,175
+70,710
| +1% | +$4.89M | 2.35% | 1 |
|
|
2020
Q4 | $419M | Buy |
6,458,465
+187,445
| +3% | +$12.2M | 2.41% | 2 |
|
|
2020
Q3 | $296M | Buy |
6,271,020
+62,910
| +1% | +$2.97M | 2.01% | 5 |
|
|
2020
Q2 | $292M | Buy |
6,208,110
+8,890
| +0.1% | +$418K | 2.09% | 3 |
|
|
2020
Q1 | $277M | Buy |
6,199,220
+132,560
| +2% | +$5.92M | 2.49% | 1 |
|
|
2019
Q4 | $354M | Buy |
6,066,660
+387,900
| +7% | +$22.6M | 2.58% | 1 |
|
|
2019
Q3 | $341M | Sell |
5,678,760
-81,470
| -1% | -$4.89M | 2.81% | 1 |
|
|
2019
Q2 | $322M | Buy |
5,760,230
+286,410
| +5% | +$16M | 2.7% | 1 |
|
|
2019
Q1 | $305M | Buy |
5,473,820
+77,845
| +1% | +$4.34M | 2.66% | 1 |
|
|
2018
Q4 | $243M | Buy |
5,395,975
+53,390
| +1% | +$2.41M | 2.47% | 1 |
|
|
2018
Q3 | $352M | Buy |
5,342,585
+211,115
| +4% | +$13.9M | 3.12% | 1 |
|
|
2018
Q2 | $331M | Buy |
5,131,470
+133,875
| +3% | +$8.62M | 3.2% | 1 |
|
|
2018
Q1 | $277M | Buy |
4,997,595
+351,520
| +8% | +$19.5M | 2.99% | 1 |
|
|
2017
Q4 | $222M | Buy |
4,646,075
+110,355
| +2% | +$5.28M | 2.52% | 3 |
|
|
2017
Q3 | $229M | Buy |
4,535,720
+88,031
| +2% | +$4.44M | 2.7% | 1 |
|
|
2017
Q2 | $242M | Buy |
4,447,689
+8,929
| +0.2% | +$487K | 2.96% | 1 |
|
|
2017
Q1 | $187M | Buy |
4,438,760
+2,468,145
| +125% | +$104M | 2.46% | 3 |
|
|
2016
Q4 | $169M | Buy |
1,970,615
+343,016
| +21% | +$29.4M | 2.34% | 5 |
|
|
2016
Q3 | $134M | Sell |
1,627,599
-15,726
| -1% | -$1.3M | 2.04% | 6 |
|
|
2016
Q2 | $131M | Buy |
1,643,325
+143,925
| +10% | +$11.5M | 2.26% | 5 |
|
|
2016
Q1 | $101M | Buy |
1,499,400
+17,525
| +1% | +$1.18M | 1.83% | 9 |
|
|
2015
Q4 | $100M | Sell |
1,481,875
-47,365
| -3% | -$3.21M | 1.72% | 9 |
|
|
2015
Q3 | $91.1M | Buy |
1,529,240
+106,055
| +7% | +$6.32M | 1.59% | 10 |
|
|
2015
Q2 | $95.9M | Sell |
1,423,185
-11,590
| -0.8% | -$781K | 1.51% | 11 |
|
|
2015
Q1 | $88.5M | Sell |
1,434,775
-10,250
| -0.7% | -$632K | 1.51% | 15 |
|
|
2014
Q4 | $78.4M | Buy |
1,445,025
+82,080
| +6% | +$4.45M | 1.25% | 23 |
|
|
2014
Q3 | $67.7M | Sell |
1,362,945
-29,300
| -2% | -$1.45M | 1.17% | 19 |
|
|
2014
Q2 | $65.5M | Buy |
1,392,245
+16,030
| +1% | +$754K | 1.07% | 22 |
|
|
2014
Q1 | $63.3M | Sell |
1,376,215
-17,165
| -1% | -$789K | 1.09% | 23 |
|
|
2013
Q4 | $66.5M | Sell |
1,393,380
-48,445
| -3% | -$2.31M | 1.17% | 20 |
|
|
2013
Q3 | $58M | Buy |
1,441,825
+3,660
| +0.3% | +$147K | 1.1% | 29 |
|
|
2013
Q2 | $52.7M | Buy |
+1,438,165
| New | +$52.7M | 1.06% | 28 |
|